Australia - engelsk - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - thiamine hydrochloride, quantity: 100 mg/ml - injection - excipient ingredients: disodium edetate; benzyl alcohol; water for injections - thiamine hydrochloride injection is used for the prevention and treatment of vitamin b1 deficiency.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - furosemide sodium, quantity: 10.664 mg/ml (equivalent: furosemide, qty 10 mg/ml) - injection, solution - excipient ingredients: sodium hydroxide; sodium chloride; water for injections - oedema: lasix is indicated in adults, infants and children for the treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease including nephrotic syndrome. lasix is particularly useful when an agent with greater diuretic potential than that of those commonly employed is desired. parenteral therapy should be reserved for patients unable to take oral medication, or for patients in emergency clinical situations. lasix injection is also indicated as adjunctive therapy in acute pulmonary and cerebral oedema where intense and rapid onset of diuresis is desired. if gastrointestinal absorption is impaired or oral medication is not practical for any reason, lasix is indicated by the intravenous route. parenteral use should be replaced with oral lasix as soon as practical.

USA - engelsk - NLM (National Library of Medicine)

general injectables & vaccines, inc - thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j) - thiamine hydrochloride 100 mg in 1 ml - thiamine hydrochloride injection is effective for the treatment of thiamine deficiency or beriberi whether of the dry (major symptoms related to the nervous system) or wet (major symptoms related to the cardiovascular system) variety. thiamine hydrochloride injection should be used where rapid restoration of thiamine is necessary, as in wernicke's encephalopathy, infantile beriberi with acute collapse, cardiovascular disease due to thiamine deficiency, or neuritis of pregnancy if vomiting is severe. it is also indicated when giving iv dextrose to individuals with marginal thiamine status to avoid precipitation of heart failure. thiamine hydrochloride injection is also indicated in patients with established thiamine deficiency who cannot take thiamine orally due to coexisting severe anorexia, nausea, vomiting, or malabsorption. thiamine hydrochloride injection is not usually indicated for conditions of decreased oral intake or decreased gastrointestinal absorption, because multiple vitamins should usually be g

USA - engelsk - NLM (National Library of Medicine)

mylan institutional llc - thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j) - thiamine hydrochloride 100 mg in 1 ml - thiamine hydrochloride injection is effective for the treatment of thiamine deficiency or beriberi whether of the dry (major symptoms related to the nervous system) or wet (major symptoms related to the cardiovascular system) variety. thiamine hydrochloride injection should be used where rapid restoration of thiamine is necessary, as in wernicke’s encephalopathy, infantile beriberi with acute collapse, cardiovascular disease due to thiamine deficiency, or neuritis of pregnancy if vomiting is severe. it is also indicated when giving iv dextrose to individuals with marginal thiamine status to avoid precipitation of heart failure. thiamine hydrochloride injection is also indicated in patients with established thiamine deficiency who cannot take thiamine orally due to coexisting severe anorexia, nausea, vomiting, or malabsorption. thiamine hydrochloride injection is not usually indicated for conditions of decreased oral intake or decreased gastrointestinal absorption, because multiple vitamins should usually be g

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 1.819 mg (equivalent: adrenaline (epinephrine), qty 1 mg) - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid; sodium hydroxide - adrenaline aguettant 1:10,000 is used as an adjunct in the management of cardiac arrest.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - furosemide sodium, quantity: 10.664 mg/ml (equivalent: furosemide, qty 10 mg/ml) - injection, solution - excipient ingredients: water for injections; sodium chloride; sodium hydroxide - oedema: lasix is indicated in adults, infants and children for the treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease, including the nephrotic syndrome. lasix is particularly useful when an agent with greater diuretic potential than that of those commonly employed is desired. parenteral therapy should be reserved for patients unable to take oral medication or for patients in emergency clinical situations. lasix injection is also indicated as adjunctive therapy in acute pulmonary oedema and cerebral oedema where intense and rapid onset of diuresis is desired. if gastrointestinal absorption is impaired or oral medication is not practical for any reason, lasix is indicated by the intravenous route. parenteral use should be replaced with oral lasix as soon as practical.

Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

fresenius kabi hellas ae Λεωφ. Κηφισίας 64Α, 151 25 Μαρούσι Αττικής 6542909 - isoleucine; leucine; lysine; methionine; phenylalanine; threonine; tryptophan, l-; valine; arginine; histidine; glycine; serine; tyrosine; taurine; alanine; proline; glycerol-1 (2)dihydrogen-phosphate a mixture of the disodium salts x 5 h2o (40/60% w/w); acetic acid; potassium hydroxide 85%; hydrochloric acid (25%); dextrose(glucose) monohydrate; sodium chloride; calcium chloride dihydrate; magnesium chloride anhydrous; zinc chloride - sol.inf (ΔΙΑΛΥΜΑ ΓΙΑ ΕΓΧΥΣΗ) - isoleucine 529,339g; leucine 3,7g; lysine 3,3g; methionine 2,15g; phenylalanine 2,55g; threonine 2,2g; tryptophan, l- 1g; valine 3,1g; arginine 6g; histidine 1,5g; glycine 5,5g; serine 3,25g; tyrosine 0,2g; taurine 0,5g; alanine 7g; proline 5,6g; glycerol-1 (2)dihydrogen-phosphate a mixture of the disodium salts x 5 h2o (40/60% w/w) 4,59; acetic acid 4,5g; potassium hydroxide 85% 1,981g; hydrochloric acid (25%) 1,65g; dextrose(glucose) monohydrate 220g; sodium chloride 1,169g; calcium chloride dihydrate 0,294g; magnesium chloride anhydrous 0,61g; zinc chloride 0,006g - combinations

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - riboflavine sodium phosphate, quantity: 5.67 mg; pyridoxine hydrochloride, quantity: 5.5 mg; cyanocobalamin, quantity: 6 microgram; nicotinamide, quantity: 46 mg; dl-alpha-tocopherol, quantity: 10.2 mg; ascorbic acid, quantity: 125 mg; retinol palmitate, quantity: 3500 iu; colecalciferol, quantity: 5.5 microgram; dexpanthenol, quantity: 16.15 mg; biotin, quantity: 69 microgram; cocarboxylase tetrahydrate, quantity: 5.8 mg (equivalent: thiamine, qty 3.51 mg); folic acid, quantity: 414 microgram - injection, powder for - excipient ingredients: glycine; glycocholic acid; hydrochloric acid; sodium hydroxide; lecithin - cernevit is indicated in adults and children over 11 years of age requiring parenteral multivitamin supplementation to correct or prevent vitamin deficiencies when oral administration is contraindicated, impossible or insufficient. the product does not contain vitamin k, which may be given separately if required.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - tramadol hydrochloride, quantity: 50 mg/ml - injection, solution - excipient ingredients: water for injections; sodium acetate - tramal solution for injection is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - tramadol hydrochloride, quantity: 50 mg/ml - injection, solution - excipient ingredients: sodium acetate; water for injections - tramal solution for injection is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.